欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4565/001
药品名称lrinotecan Hydrochloride Trihydrate 20 mg/ml,
活性成分
    • irinotecan hydrochloride 3 H<2>O 20.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare Limited. Sage House. 319 Pinner Road. Not1h Harrow. Middlesex. HA I 4HF, UK.
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Irinotecan Accord 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
      Irinotecan Accord
    • Belgium (BE)
      Irinotecan Accord 20 mg/ml Solution à diluer pour perfusion
    • Iceland (IS)
      Irinotecan Accord 20 mg/ml Innrennslisþykkni, lausn
    • Ireland (IE)
    • Austria (AT)
      Irinotecan Accord 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      IRINOTECAN/ACCORD
    • Sweden (SE)
    • Norway (NO)
      Irinotecan Accord
    • Finland (FI)
    • Poland (PL)
      Irinotecan Accord
    • Latvia (LV)
      Irinotecan Accord 20 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Irinotecan Accord 20 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      IRINOTECAN ACCORD
    • Hungary (HU)
      IRINOTECAN ACCORD 20 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Irinotecan Accord
    • Cyprus (CY)
    • Czechia (CZ)
      Irinotecan Accordpharma 20 mg/ml koncentrát pro infuzní roztok
    • Romania (RO)
      Irinotecan Accord 20 mg/ml concentrat pentru soluţie perfuzabilă
    • Slovakia (SK)
      Irinotecan Accord 20 mg/ml infúzny koncentrát
    • Slovenia (SI)
    • Croatia (HR)
      Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju
许可日期2016/05/19
最近更新日期2024/04/26
药物ATC编码
    • L01XX19 irinotecan
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase